Dublin, April 20, 2026 (GLOBE NEWSWIRE)-- The "Viral Vector and Plasmid DNA Manufacturing Market (7th Edition): Industry Trends and Global Forecasts, till 2035" report has been added to ...
Vector BioMed is the latest entry into the viral vector CDMO arena after raising $15 million in a first round of funding in hopes of helping reduce the manufacturing gap in the cell and gene therapy ...
Viral vectors are engineered viruses used to deliver gene therapies, gene-modified cell therapies—such as Kite’s CAR-Ts Yescarta and Tecartus—as well as certain ...
The global viral vector manufacturing market is projected to expand at a robust CAGR of approximately 20% over the forecast period, supported by multiple transformative forces reshaping the ...
MALVERN, Pa.--(BUSINESS WIRE)--Vector Biolabs, a custom design and manufacturing service provider for AAV and adenovirus viral vectors announced the completion of a facility expansion to meet growing ...
Brianna Jayanthi, PhD, is a principal scientist at Asimov, where she has helped lead the development of next-generation cell lines for viral vector manufacturing. Since joining Asimov in 2019, she has ...
Pharmaceutical Technology spoke with Colleen Floreck, vice president, Global Marketing and Strategy, Catalent Cell and Gene Therapy about the specific requirements and challenges for expanding ...
Option agreement Supports Vector's Entry into the $80.8 Billion Peptide Market with 22 Novel Pharmaceutical-Grade Formulations FDA-Registered, cGMP Manufacturing-- MPP operates a modern 35,000 sq. ft.
Vector Biolabs, a custom design and manufacturing service provider for AAV and adenovirus viral vectors announced the completion of a facility expansion to meet growing demand. The purpose of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results